Rodríguez-Carranza SI

Language: Spanish
References: 21
Page: 33-35
PDF size: 88.52 Kb.

Text Extraction

No abstract

REFERENCES

1. Leahy JL. Pathogenesis of type 2 diabetes mellitus. Arch Med Res 2005; 36(3): 197-209.

2. Colagiuri S, Borch-Johnsen K, Glümer C, Vistisen D. There really is an epidemic of type 2 diabetes. Diabetologia 2005; 48(8): 1459-1463.

3. Knowler WC, Barret-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.

4. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.

5. Elbein SC, Chu W, Ren Q, Hemphill C, Schay J, Cox NJ, Hanis CL, Hasstedt SJ. Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians. J Clin Endocrinol Metab 2002; 87(2): 650-654.

6. Barnett AH, Eff C, Leslie RD, Pyke DA. Diabetes in identical twins. A study of 200 pairs. Diabetologia 1981; 20: 87-93.

7. Hanis CL, Boerwinkle E, Chakraborty R, Ellsworth DL, Concannon P et al. A genome-wide search for human non-insulindependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 1996; 13: 161-166.

8. Marshall C, Hitman GA, Partridge CJ, Clark A, Ma H, Shearer TR. Evidence that an isoform of calpain-10 is a regulator of exocytosis in pancreatic β-cells. Mol Endocrinol 2005; 19: 213-224.

9. Reynisdottir I, Thorleifsson G, Benediktsson R, Sigurdsson G, Emilsson V et al. Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2. Am J Hum

10. Genet 2003; 73: 323-335.

11. Yi F, Brubaker PL, Jin T. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3 beta. J Biol Chem 2005; 280: 1457-1464.

12. Leahy JL. Pathogenesis of type 2 diabetes mellitus. Arch Med Res 2005; 36(3): 197-209.

13. Colagiuri S, Borch-Johnsen K, Gl¨¹mer C, Vistisen D. There really is an epidemic of type 2 diabetes. Diabetologia 2005; 48(8): 1459-1463.

14. Knowler WC, Barret-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.

15. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.

16. Elbein SC, Chu W, Ren Q, Hemphill C, Schay J, Cox NJ, Hanis CL, Hasstedt SJ. Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians. J Clin Endocrinol Metab 2002; 87(2): 650-654.

17. Barnett AH, Eff C, Leslie RD, Pyke DA. Diabetes in identical twins. A study of 200 pairs. Diabetologia 1981; 20: 87-93.

18. Hanis CL, Boerwinkle E, Chakraborty R, Ellsworth DL, Concannon P et al. A genome-wide search for human non-insulindependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 1996; 13: 161-166.

19. Marshall C, Hitman GA, Partridge CJ, Clark A, Ma H, Shearer TR. Evidence that an isoform of calpain-10 is a regulator of exocytosis in pancreatic β-cells. Mol Endocrinol 2005; 19: 213-224.

20. Reynisdottir I, Thorleifsson G, Benediktsson R, Sigurdsson G, Emilsson V et al. Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2. Am J Hum Genet 2003; 73: 323-335.

21. Yi F, Brubaker PL, Jin T. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3 beta. J Biol Chem 2005; 280: 1457-1464.